The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.

Cunzhen ShiXiangqun LiXiaogan WangNing DingLingyan PingYunfei ShiLan MiYumei LaiYuqin SongJun Zhu

Published in: Journal of hematology & oncology (2018)

Our data prove that ectopic MerTK may be a novel therapeutic target in MCL, and further pre-clinical or even clinical studies of UNC2250 or new MerTK inhibitors are essential and of great significance.

Keyphrases

tyrosine kinase
epidermal growth factor receptor
electronic health record
big data
machine learning
data analysis
artificial intelligence